FDA Orange Book

Generic for Rydapt

Rydapt contains midostaurin. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

Yes. The generic name for Rydapt is midostaurin. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.

Run it in Rivvi

Map Rydapt and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Rydapt products in the Orange Book

Rydapt products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
capsule, oral25MGMarketed (Rx)AB2AB

NDA 207997, held by NOVARTIS PHARMACEUTICALS CORP. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Approved generic midostaurin

Approved generic versions of Rydapt
CompanyANDATE codeApprovedStrengths
LUPIN INC216015AB (A-rated, therapeutically equivalent)May 10, 202425MG
DR REDDYS LABORATORIES LTD215921AB (A-rated, therapeutically equivalent)June 28, 202425MG

Rydapt patents

Patents listed for Rydapt
PatentExpiresCoversUse codeNDA
7973031October 9, 2028Method of useU-2007207997
8575146December 2, 2030Method of useU-2008207997

Rydapt NDC codes

Questions

Is there a generic for Rydapt?

Yes. The generic name for Rydapt is midostaurin. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.

What is the generic name for Rydapt?

The active ingredient in Rydapt is midostaurin, per the FDA Orange Book.

When does the Rydapt patent expire?

The last patent listed for Rydapt in the Orange Book expires December 2, 2030. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Rydapt and Midostaurin

Try it on your own data today.

Free to start. Most teams are using it the same day.